Current Role:
John joined Almac Pharma Services, part of Almac Group in 2003 and was appointed VP Technical Operations in 2011, responsible for the Pharmaceutical Development Department which brings together Formulation Development, Analytical Support and Project Management. John was appointed Managing Director and President of Almac Pharma Services in 2022 and will now be responsible for overall strategic, operational and financial leadership of the Almac Pharma Services business.
John has extensive product development, quality assurance and validation experience with direct experience of hosting product pre-approval inspections by the FDA as well as inspections from other regulatory authorities. Experience of technical, quality and regulatory related requirements for different phases of drug product development.
Experience:
Overall responsibility for Almac Pharma Services Business Unit. John graduated from University of Ulster with a BSc Honours degree. John first joined Almac Group in 1994 and has held a number of management roles across various business units during his tenure. In 2011 he was appointed to Vice President of Technical Operations within Almac Pharma Services where he was responsible for overseeing the strategic growth and development of the Pharmaceutical Development & Manufacturing service offering. John was promoted to President and Managing Director, Almac Pharma Services, in 2022 and is responsible for the strategic, financial and operational leadership of global business.
Joined Almac:
2003
